FI98988C - Varjoaineita - Google Patents

Varjoaineita

Info

Publication number
FI98988C
FI98988C FI920238A FI920238A FI98988C FI 98988 C FI98988 C FI 98988C FI 920238 A FI920238 A FI 920238A FI 920238 A FI920238 A FI 920238A FI 98988 C FI98988 C FI 98988C
Authority
FI
Finland
Prior art keywords
contrast agents
water soluble
containing substance
metal species
physiologically tolerable
Prior art date
Application number
FI920238A
Other languages
English (en)
Swedish (sv)
Other versions
FI920238A0 (fi
FI98988B (fi
Inventor
Jo Klaveness
Original Assignee
Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed As filed Critical Nycomed As
Publication of FI920238A0 publication Critical patent/FI920238A0/fi
Application granted granted Critical
Publication of FI98988B publication Critical patent/FI98988B/fi
Publication of FI98988C publication Critical patent/FI98988C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/806—Electrical property or magnetic property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Liquid Crystal (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Steroid Compounds (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
FI920238A 1989-07-21 1992-01-20 Varjoaineita FI98988C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898916781A GB8916781D0 (en) 1989-07-21 1989-07-21 Compositions
PCT/EP1990/001197 WO1991001149A1 (en) 1989-07-21 1990-07-19 Contrast media

Publications (3)

Publication Number Publication Date
FI920238A0 FI920238A0 (fi) 1992-01-20
FI98988B FI98988B (fi) 1997-06-13
FI98988C true FI98988C (fi) 1997-09-25

Family

ID=10660460

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920238A FI98988C (fi) 1989-07-21 1992-01-20 Varjoaineita

Country Status (13)

Country Link
US (1) US5242683A (fi)
EP (2) EP0414288B1 (fi)
JP (1) JP3054660B2 (fi)
AT (1) ATE103183T1 (fi)
AU (1) AU641422B2 (fi)
CA (1) CA2055604A1 (fi)
DE (1) DE69007575T2 (fi)
DK (1) DK0414288T3 (fi)
ES (1) ES2052161T3 (fi)
FI (1) FI98988C (fi)
GB (1) GB8916781D0 (fi)
NO (1) NO302797B1 (fi)
WO (1) WO1991001149A1 (fi)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
GB8916782D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
US5547682A (en) * 1989-12-22 1996-08-20 Bioquest, Incorporated Preparation and use of novel injectable RES avoiding inorganic particles for medical application
DE4115789A1 (de) * 1991-05-10 1992-11-12 Schering Ag Makrocyclische polymer-komplexbildner, deren komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
EP0703790B1 (en) * 1993-06-02 2000-08-16 BRACCO S.p.A. Iodinated paramagnetic chelates, and their use as contrast agents
US6071300A (en) 1995-09-15 2000-06-06 Sub-Q Inc. Apparatus and method for percutaneous sealing of blood vessel punctures
US6071301A (en) 1998-05-01 2000-06-06 Sub Q., Inc. Device and method for facilitating hemostasis of a biopsy tract
US6162192A (en) 1998-05-01 2000-12-19 Sub Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6183497B1 (en) 1998-05-01 2001-02-06 Sub-Q, Inc. Absorbable sponge with contrasting agent
DE19641197C2 (de) * 1996-09-24 1999-02-18 Schering Ag Ionenpaare und ihre Verwendung als Kontrastmittel
FR2772025B1 (fr) * 1997-12-10 2000-03-03 Guerbet Sa Chelates metalliques de macrocycles polyaminocarboxyliques et leur application a l'imagerie par resonance magnetique
US6200328B1 (en) 1998-05-01 2001-03-13 Sub Q, Incorporated Device and method for facilitating hemostasis of a biopsy tract
US6610026B2 (en) 1998-05-01 2003-08-26 Sub-Q, Inc. Method of hydrating a sponge material for delivery to a body
US7625352B1 (en) 1998-05-01 2009-12-01 Sub-Q, Inc. Depth and puncture control for system for hemostasis of blood vessel
US6315753B1 (en) 1998-05-01 2001-11-13 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US20010045575A1 (en) 1998-05-01 2001-11-29 Mark Ashby Device and method for facilitating hemostasis of a biopsy tract
JP4271375B2 (ja) 1999-02-10 2009-06-03 サブ−キュー・インコーポレーテッド 生検管路の止血を容易とするためのデバイスおよび方法
US6984219B2 (en) 1999-09-23 2006-01-10 Mark Ashby Depth and puncture control for blood vessel hemostasis system
US7695492B1 (en) 1999-09-23 2010-04-13 Boston Scientific Scimed, Inc. Enhanced bleed back system
US6540735B1 (en) 2000-05-12 2003-04-01 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US7201725B1 (en) 2000-09-25 2007-04-10 Sub-Q, Inc. Device and method for determining a depth of an incision
EP1406671A1 (en) 2001-03-12 2004-04-14 Sub Q, Inc. Methods for sterilizing cross-linked gelatin compositions
US8187625B2 (en) 2001-03-12 2012-05-29 Boston Scientific Scimed, Inc. Cross-linked gelatin composition comprising a wetting agent
US6584355B2 (en) * 2001-04-10 2003-06-24 Cardiac Pacemakers, Inc. System and method for measuring battery current
US6863680B2 (en) * 2001-11-08 2005-03-08 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7029489B1 (en) 2001-05-18 2006-04-18 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site
US7008440B2 (en) 2001-11-08 2006-03-07 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7037323B2 (en) 2001-11-08 2006-05-02 Sub-Q, Inc. Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7037322B1 (en) 2001-11-08 2006-05-02 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture with a staging tube
US7192436B2 (en) 2001-11-08 2007-03-20 Sub-Q, Inc. Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
WO2004009064A1 (de) * 2002-07-19 2004-01-29 Mestex Ag Verwendung von neurotoxischen substanzen für die herstellung eines mittels zur behandlung von gelenkschmerzen und verfahren zur applikation dieses mittels
US20040102730A1 (en) * 2002-10-22 2004-05-27 Davis Thomas P. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US7455680B1 (en) 2002-11-04 2008-11-25 Boston Scientific Scimed, Inc. Apparatus and method for inhibiting blood loss
US8317821B1 (en) 2002-11-04 2012-11-27 Boston Scientific Scimed, Inc. Release mechanism
US7955353B1 (en) 2002-11-04 2011-06-07 Sub-Q, Inc. Dissolvable closure device
US7378081B2 (en) * 2003-01-29 2008-05-27 Vincon Research Enterprises, Llc Composition and method for direct visualization of the human appendix
US20050180920A1 (en) * 2003-01-29 2005-08-18 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
US20040265235A1 (en) * 2003-06-26 2004-12-30 Uzgiris Egidijus Edward Magnetic resonance contrast-enhancing agents and method for detecting and imaging artherosclerotic plaque
US7875043B1 (en) 2003-12-09 2011-01-25 Sub-Q, Inc. Cinching loop
WO2006068639A1 (en) * 2004-12-21 2006-06-29 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
US7384624B2 (en) * 2004-12-27 2008-06-10 James Raines Oral contrast and method of producing the oral contrast
WO2006069677A2 (en) * 2004-12-30 2006-07-06 Cinvention Ag Combination comprising an agent providing a signal, an implant material and a drug
CN101098916A (zh) * 2005-01-13 2008-01-02 金文申有限公司 含有碳纳米颗粒的复合材料
US8703097B2 (en) * 2005-02-11 2014-04-22 University Health Network Compositions and method for multimodal imaging
CN101142149A (zh) * 2005-03-18 2008-03-12 金文申有限公司 制备多孔烧结金属材料的方法
CA2612195A1 (en) * 2005-07-01 2007-01-11 Cinvention Ag Medical devices comprising a reticulated composite material
EA200801110A1 (ru) * 2005-10-18 2008-10-30 Синвеншен Аг Частицы на основе термореактивных смол и способы их получения
EP2029184B1 (en) * 2006-05-26 2011-02-23 Baxter International Inc. Injectable fibrin composition for bone augmentation
DK2021043T3 (da) * 2006-05-26 2011-04-04 Baxter Int Injicerbart fyldstof til knoglehulrum
US8601223B1 (en) 2006-09-19 2013-12-03 Nvidia Corporation Techniques for servicing fetch requests utilizing coalesing page table entries
KR101512863B1 (ko) 2007-03-26 2015-04-16 백스터 인터내셔널 인코포레이티드 주입 가능한 연조직 증강용 공극 충전제
KR101585751B1 (ko) * 2010-07-12 2016-01-14 지이 헬스케어 에이에스 저농도의 조영제 및/또는 저방사선량의 x-선 영상화
CN104114190A (zh) 2012-01-11 2014-10-22 通用电气医疗集团股份有限公司 具有低碘浓度的x-射线成像造影介质和x-射线成像方法
MX2016007347A (es) * 2013-12-04 2016-10-26 Hovione Scientia Ltd Formulaciones de enmascaramiento del sabor de medios de contraste.

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2387735A (en) * 1941-07-03 1945-10-30 Martin Dennis Company Method of forming carboxylic amino acids
US2407645A (en) * 1943-06-21 1946-09-17 Martin Dennis Company Aliphatic polycarboxylic amino acids and process of making them
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3316703A1 (de) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen Orales kontrastmittel fuer die kernspintomographie und dessen herstellung
DE3324235A1 (de) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Neue komplexbildner, komplexe und komplexsalze
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
US5013831A (en) * 1984-01-30 1991-05-07 Enzo Biochem, Inc. Detectable molecules, method of preparation and use
GB8413772D0 (en) * 1984-05-30 1984-07-04 Nyegaard & Co As Chemical compounds
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
DE3577185D1 (de) * 1984-11-01 1990-05-23 Nycomed As Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
US4880008A (en) * 1985-05-08 1989-11-14 The General Hospital Corporation Vivo enhancement of NMR relaxivity
NZ212437A (en) * 1985-06-17 1992-06-25 Mark Philip Best Site-directed antibody conjugates, and their preparation
JPS62153229A (ja) * 1985-12-27 1987-07-08 Nippon Oil Co Ltd 皮膚マ−カ−
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
IT1213029B (it) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
US5104641A (en) * 1986-03-07 1992-04-14 M.R.I., Inc. Nitroxide NMR contrast enhancing agents and their use in NMR imaging
AU608759B2 (en) * 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
DE3701665A1 (de) * 1987-01-19 1988-07-28 Schering Ag Polymer-komplexe, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
EP0299795B1 (en) * 1987-07-16 1992-03-18 Nycomed As Aminopolycarboxylic acids and derivatives thereof
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions

Also Published As

Publication number Publication date
CA2055604A1 (en) 1991-01-22
EP0414288A1 (en) 1991-02-27
AU6143890A (en) 1991-02-22
EP0473729A1 (en) 1992-03-11
ATE103183T1 (de) 1994-04-15
JP3054660B2 (ja) 2000-06-19
EP0414288B1 (en) 1994-03-23
NO920261L (no) 1992-01-20
AU641422B2 (en) 1993-09-23
DE69007575T2 (de) 1994-07-21
US5242683A (en) 1993-09-07
DE69007575D1 (de) 1994-04-28
DK0414288T3 (da) 1994-04-11
GB8916781D0 (en) 1989-09-06
FI920238A0 (fi) 1992-01-20
JPH04506807A (ja) 1992-11-26
NO302797B1 (no) 1998-04-27
FI98988B (fi) 1997-06-13
ES2052161T3 (es) 1994-07-01
WO1991001149A1 (en) 1991-02-07
NO920261D0 (no) 1992-01-20

Similar Documents

Publication Publication Date Title
FI98988B (fi) Varjoaineita
DE69027799D1 (de) Chemisch amplifizierter Photolack
EP0279307A3 (en) Bifunctional chelating agents
FI842912A0 (fi) Oftalmologisk kombinationsapparat foer diagnos och terapi.
DE3869446D1 (de) Desodorierungsmittel.
DE59009531D1 (de) Röntgenröhre.
DK728988D0 (da) Chelaterende forbindelser og anvendelse deraf
FR2641890B1 (fr) Mecanisme de chargement d'un disque
EP0165994A4 (en) CONTRAST AGENTS AND THEIR METHOD OF USE.
DE3788131D1 (de) Anzeigevorrichtung für den bereits abgelaufenen teil der lebensdauer eines transformators.
GB2020381B (en) Electromagnet for use with electrically-controlled brake
DE3163087D1 (en) Radioactive diagnostic agent for bone scanning and non-radioactive carrier therefor
DE68902206D1 (de) Bariumsulfat enthaltende roentgenkontrastmittel zur untersuchung des dickdarms.
FI98987B (fi) Varjoainekoostumus
DE58905402D1 (de) Röntgenstrahler.
DE69013088D1 (de) Entwicklungseinheit eines Bilderzeugungsgerätes.
IT8221361A0 (it) Veicolo. procedimento e dispositivo per misurare l'azione frenante di un
ES513907A0 (es) "perfeccionamientos en los mecanismos de freno".
ES2157267T3 (es) Procedimiento y reactivo para la determinacion de hierro.
DE68922645D1 (de) Röntgenstrahlmaske.
FR2616558B1 (fr) Composition photosensible developpable a l'eau, comprenant un agent photoreticulant
GB2027696B (en) X-ray contrast agents
IT1209509B (it) Dispositivo per l'agganciamento rotante e lo sganciamento rapidi di un pezzo per odontoiatria.
GB8806930D0 (en) Chelating agent & its use
IT8423620A0 (it) Apparecchio per il trattamento di pellicole radiografiche per uso dentario e procedimento per ottenere un'immagine radiografica dentaria.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed